Prolacta Bioscience Company

Prolacta Bioscience provides human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU).
Technology: Stem cell therapy, Stem cells therapy
Industry: Longevity, Private
Headquarters: City Of Industry, California, United States
Founded Date: 1999-01-01
Employees Number: 101-250
Investors Number: 12
Total Funding: 78043517
Estimated Revenue: $50M to $100M
Last Funding Date: 2018-05-15
Last Funding Type: Venture - Series Unknown

Visit Website
info@prolacta.com
http://twitter.com/prolacta
Register and Claim Ownership